Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公司

Pay for financial year ended 2020-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chan, Peter Kin Sang 陳健生 INED 89 89
2 Cheng, Gary Faat Ting 鄭發丁 INED 34 34
3 Chow, Joseph Kwok Fai 周國輝 INED 4 4
4 He, Jiaming (1985) 何嘉明 ED 445 36 409 890
5 Kwok, Wilson Chi Shing 郭志成 INED 56 56
6 Poon, Michael Lai Yin 潘禮賢 FD 838 36 409 1,283
7 Yeung, David Wai Chow 楊煒秋 INED 85 85
8 Zhang, Chunguang (1968) 張春光 CEO 278 40 409 727
9 Zhang, Shuguang (1970) 張曙光 Ch 240 27 409 676
Total 268 1,801 139 0 1,636 3,844

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 418 1,618 510 228 0 2,774 Report
2023-12-31 308 1,708 516 211 0 2,743 Report
2022-12-31 258 2,065 668 0 0 2,991 Report
2021-12-31 249 2,053 151 0 0 2,453 Report
2020-12-31 268 1,801 139 0 1,636 3,844 Report
2019-12-31 264 787 181 0 0 1,232 Report
2018-12-31 12 440 39 58 0 549 Report
Total 1,777 10,472 2,204 497 1,636 16,586

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top